MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Diabetes Treatment and Management
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

3,896 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
3,896 works in the cohort · of 4,299,418page 3 of 78

Labels cover 11 of 3,896 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 3,896 of 3,896 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Minireview: The Glucagon-Like Peptides
Daniel J. Drucker
2001· review· en· Endocrinology· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
397
citations
affno abstractunlabeled
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
David Z.I. Cherney, Bernard Zinman, Silvio E. Inzucchi, Audrey Koitka‐Weber, Michaela Mattheus, Maximilian von Eynatten +1 more
2017· article· en· The Lancet Diabetes & Endocrinology· Medicine
distilled prediction:candidate · noneconsensus · none
373
citations
affno abstractunlabeled
Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes
Stephen Gough, Bruce W. Bode, Vincent Woo, Helena W. Rodbard, Sultan Linjawi, Pernille Poulsen +2 more
2014· article· en· The Lancet Diabetes & Endocrinology· Medicine
distilled prediction:candidate · noneconsensus · none
362
citations
affno abstractunlabeled
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
Erik J.M. van Bommel, Marcel H.A. Muskiet, Michaël J.B. van Baar, Lennart Tonneijck, Mark M. Smits, Anna L. Emanuel +11 more
2019· article· en· Kidney International· Medicine
distilled prediction:candidate · noneconsensus · none
341
citations
afffundunlabeled
The Effect of Oral Antidiabetic Agents on A1C Levels
Diana Sherifali, Kara Nerenberg, Eleanor Pullenayegum, Ji Cheng, Hertzel C. Gerstein
2010· review· en· Diabetes Care· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
318
citations

How this was built: Screen · Findings · About